Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
CD160 is an 27 kDa glycoprotein which was initially identified with the monoclonal antibody BY55. Zusätzlich bieten wir Ihnen CD160 Proteine (20) und CD160 Kits (9) und viele weitere Produktgruppen zu diesem Protein an.
Showing 10 out of 188 products:
Human Monoclonal CD160 Primary Antibody für FACS, IP - ABIN1981901
Bensussan, Gluckman, el Marsafy, Schiavon, Mansur, Dausset, Boumsell, Carosella: BY55 monoclonal antibody delineates within human cord blood and bone marrow lymphocytes distinct cell subsets mediating cytotoxic activity. in Proceedings of the National Academy of Sciences of the United States of America 1994
Show all 4 Pubmed References
Human Monoclonal CD160 Primary Antibody für FACS, IP - ABIN2749166
Giustiniani, Bensussan, Marie-Cardine: Identification and characterization of a transmembrane isoform of CD160 (CD160-TM), a unique activating receptor selectively expressed upon human NK cell activation. in Journal of immunology (Baltimore, Md. : 1950) 2008
Show all 2 Pubmed References
Human Monoclonal CD160 Primary Antibody für FACS - ABIN4898078
de Mare-Bredemeijer, Shi, Mancham, van Gent, van der Heide-Mulder, de Boer, Heemskerk, de Jonge, van der Laan, Metselaar, Kwekkeboom: Cytomegalovirus-Induced Expression of CD244 after Liver Transplantation Is Associated with CD8+ T Cell Hyporesponsiveness to Alloantigen. in Journal of immunology (Baltimore, Md. : 1950) 2015
CD160 may represent a suitable target for immune intervention in the setting of transplantation to modulate allogeneic cytotoxic responses.
CD160 functionally controls cytokine production by natural killer cells.
Report additive effects of IL-22 (zeige IL22 Antikörper) and CD160 in mediating the pro-inflammatory and pro-survival aspects of the host mucosal response in Clostridium difficile infection.
During chronic infection the number of CD4 (zeige CD4 Antikörper)(+) T cells expressing programmed death-1 (zeige PDCD1 Antikörper) and CD160 were greater over the time-course study than the other CD4 (zeige CD4 Antikörper)(+) T-cell inhibitory ligands.
CD160 signaling is particularly important in CD28 (zeige CD28 Antikörper)-independent effector/memory CD8 (zeige CD8A Antikörper)(+) alloreactive T cell activation in vivo and therefore may serve as a novel target for prevention of allograft rejection.
soluble CD160, produced by mast cells, may have a role in T-cell-mast cell interactions in vivo
CD160 is expressed on the majority of CD8 (zeige CD8A Antikörper)(+) memory T cells as well as recently activated CD8 (zeige CD8A Antikörper)(+) T cells
CD160 and CD200 (zeige CD200 Antikörper) are expressed in B cells in chronic lymphocytic leukemia and are absent in other mature B-cell neoplasms.
Data suggest that CD160 may become a useful marker in the clinical diagnosis and prognosis of chronic lymphocytic leukemia.
elevated CD160 expression on natural killer (NK) cells plays an important role in NK cell loss in atherosclerosis.
CD160-expressing human NK cells are costimulated by HVEM (zeige TNFRSF14 Antikörper) expressed in the environment to enhance cytolytic function and cytokine production.
analysis of how NK1 receptor Gs versus Gq proteins and beta-arrestin signaling is determined by interactions in the water hydrogen bond network
identified 13 ADCC-activated genes. Six gene expression assays including 8 of the 13 genes (CCL3 (zeige CCL3 Antikörper), CCL4/CCL4L1 (zeige CCL4 Antikörper)/CCL4L2, CD160, IFNG (zeige IFNG Antikörper), NR4A3 (zeige NR4A3 Antikörper) and XCL1 (zeige XCL1 Antikörper)/XCL2 (zeige XCL2 Antikörper)) were analyzed in 127 kidney biopsies
report high frequencies of CD160 on CD8 (zeige CD8A Antikörper)+ T cells, with significantly higher levels on HTLV-1 specific CD8 (zeige CD8A Antikörper)+ T cells
A population of CD4 (zeige CD4 Antikörper)+ CD160+ T lymphocytes was identified in circulating cutaneous T cells.
Antibodies targeting CD160-GPI (zeige GNPDA1 Antikörper) complement the blockade of PD-1 (zeige PDCD1 Antikörper) to enhance HIV-specific T-cell responses and warrant further investigation in the development of novel immunotherapeutic approaches.
CD160 and PD-1 (zeige PDCD1 Antikörper) co-expression on HIV-specific CD8 (zeige CD8A Antikörper) T cells defines a subset with advanced dysfunction.
CD160 is an 27 kDa glycoprotein which was initially identified with the monoclonal antibody BY55. Its expression is tightly associated with peripheral blood NK cells and CD8 T lymphocytes with cytolytic effector activity. The cDNA sequence of CD160 predicts a cysteine-rich, glycosylphosphatidylinositol-anchored protein of 181 amino acids with a single Ig-like domain weakly homologous to KIR2DL4 molecule. CD160 is expressed at the cell surface as a tightly disulfide-linked multimer. RNA blot analysis revealed CD160 mRNAs of 1.5 and 1.6 kb whose expression was highly restricted to circulating NK and T cells, spleen and small intestine. Within NK cells CD160 is expressed by CD56dimCD16+ cells whereas among circulating T cells its expression is mainly restricted to TCRgd bearing cells and to TCRab+CD8brightCD95+CD56+CD28-CD27-cells. In tissues, CD160 is expressed on all intestinal intraepithelial lymphocytes. CD160 shows a broad specificity for binding to both classical and nonclassical MHC class I molecules.
, CD160 antigen
, natural killer cell BY55
, natural killer cell receptor BY55
, CD160 transmembrane isoform
, CD160-delta Ig
, natural killer cell receptor, immunoglobulin superfamily member